Malignant Pleural Mesothelioma (MPM) Presenting as Hydropneumothorax

被引:0
|
作者
Kuramochi, Masami [1 ]
Muraoka, Takuma [1 ]
Shinonaga, Mayumi [1 ]
Ohtani, Haruo [2 ]
Kuraoka, Setsuo [1 ]
机构
[1] Mito Saiseikai Gen Hosp, Thorac Surg, Mito, Japan
[2] Mito Saiseikai Gen Hosp, Pathol, Mito, Japan
关键词
malignant pleural mesothelioma; hydropneumothorax; pleural effusion; pneumothorax; immune; checkpoint inhibitor; PNEUMOTHORAX;
D O I
10.7759/cureus.41243
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An 86-year-old man presented with bilateral lower limb edema and was found to have hydropneumothorax on chest radiography. CT revealed a substantial pleural effusion and plaques. The patient had a history of working in a stone workshop, but the extent of asbestos exposure remained unknown. Thoracic drainage and subsequent thoracoscopic surgery confirmed the presence of biphasic malignant mesothelioma through pathological examination. Hydropneumothorax as a presentation of malignant pleural mesothelioma (MPM) is rare, with only a few similar cases reported. Remarkably, despite the coexistence of plural effusion and pneumothorax, the patient did not experience dyspnea. The examination also revealed tumor rupture and disruption of the pleura. Considering the possibility of MPM in patients with asymptomatic hydropneumothorax is essential for early diagnosis and appropriate management.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] A Phase II Trial of Nintedanib in Recurrent Malignant Pleural Mesothelioma (MPM)
    Wozniak, A.
    Schneider, B.
    Kalemkerian, G.
    Daly, R.
    Chen, W.
    Ventimiglia, J.
    Nagasaka, M.
    Zauderer, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S343 - S343
  • [42] Healthcare Professional Perceptions of Chemotherapy in Treatment of Malignant Pleural Mesothelioma (MPM)
    Kao, Steven
    Dhillon, Haryana
    Warby, Anne
    Vardy, Janette
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S629 - S629
  • [43] Combination efficacy of mTOR and MEK inhibitor in malignant pleural mesothelioma (MPM).
    Matsumoto, Seiji
    Orui, Hayato
    Kuroda, Ayumi
    Hashimoto, Masaki
    Yoneda, Kazue
    Takuwa, Teruhisa
    Kondo, Nobuyuki
    Hasegawa, Seiki
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] Malignant pleural mesothelioma (MPM): Trimodality therapy in a single center.
    Taverna, C
    Stahel, RA
    Bodis, S
    Russi, EW
    Weder, W
    ANNALS OF ONCOLOGY, 2000, 11 : 123 - 123
  • [45] Pemetrexed for malignant pleural mesothelioma (MPM): updated experience in Northern Ireland
    Fenton, A.
    Harney, J.
    Stewart, D.
    Scullin, P.
    LUNG CANCER, 2011, 71 : S16 - S16
  • [46] Immunotherapy, the promise for present and future of malignant pleural mesothelioma (MPM) treatment
    Gounant, Valerie
    Brosseau, Solenn
    Zalcman, Gerard
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [47] ASSESSMENT OF CIRCULATING MIRNAS AS POTENTIAL BIOMARKERS FOR MALIGNANT PLEURAL MESOTHELIOMA (MPM)
    Kirschner, M. B.
    Cheng, Y. Y.
    Badrian, B.
    Creaney, J.
    Edelman, J. J.
    Musk, A. W.
    Robinson, B. W.
    Klebe, S.
    van Zandwijk, N.
    Reid, G.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S83 - S83
  • [48] Weekly Epirubicin as palliative treatment in patients with malignant pleural mesothelioma (MPM)
    Belloni, P.
    Cozzi, C.
    Zannier, F.
    Della Torre, S.
    Toniolo, D.
    Corradini, G. M.
    Candido, P.
    Bollina, R.
    ANNALS OF ONCOLOGY, 2016, 27
  • [49] Single-Agent Pembrolizumab for Patients with Malignant Pleural Mesothelioma (MPM)
    Alley, Evan W.
    Schellens, Jan H. M.
    Santoro, Armando
    Beckey, Kim
    Yuan, Shuai Sammy
    Cheng, Jonathan
    Piperdi, Bilal
    Molife, L. Rhoda
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S195 - S195
  • [50] Diagnostic Yield of Pleural Fluid Cytology and Endoscopic Visceral Pleural Involvement in Malignant Pleural Mesothelioma (MPM).
    Pinelli, V.
    Marchetti, G. P.
    Bercich, L.
    Tironi, A.
    Tassi, G. F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179